DotBlu snags $2M for gaming social network
Online gaming community DotBlu has raised $2 million in first-round funding from D.E. Shaw and Maple Investments. The San Francisco-based site lets users play aracade and betting games, earn and spend “BluBucks” on virtual cars, houses and gifts, and create and take quizzes. Players create profiles and avatars that they can then trick out also using BluBucks.
The year-old startup initially launched as a betting site called BluBet. It received $225,000 in seed funding from investors… Continue Reading
Silverpop, an on-demand marketer, takes $15M
Silverpop, an Atlanta-based marketing technology firm that focuses on email, has taken $15 million in additional funds for expansion, despite reported profitability since 2004.
Silverpop offers both business-to-customer and business-to-business marketing tools, and also provides measurement and analytics. The company is planning on expanding into the international market.
The $15 million round was led by D.E. Shaw, with participation from Draper Fisher Jurvetson, which also invested in past rounds.
Life sciences briefing: Thursday, Oct. 25, 2007
Featured companies: BioVex, Cavadis, Innovention, Paratek Pharmaceuticals, Phase Bioscience, Reliant Pharmaceuticals, Xencor
UPDATED: Expanded Paratek and Xencor items.
Paratek Pharma raises $40M for new antibiotics — Boston’s Paratek Pharmaceuticals, a biotech working on new antibiotics to treat drug-resistant bacterial infections, raised a first tranche of a $40 million eighth round of funding. The company’s release is here, VentureWire (subscription required) has more details here.
Investors in this funding included Aisling Capital, D.E. Shaw, Boston Life Science Venture Corporation, Nomura Phase4… Continue Reading